Stephen Williams, MD

Stephen B. Williams, MD, discusses the rationale for the phase 3 SunRISE-2 trial in muscle-invasive bladder cancer.

There is no magic door to walk through at the end of our training (whether that be residency or fellowship) that leads to the perfect job.